Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Senator Schumer to Introduce Bill to Decriminalize Marijuana

Published: Fri, 20 Apr 2018 18:26:25 EDT
The proposed legislation would also call for further research into the drug's potential benefits and risks.
Medscape Medical News

Prediabetes, Diabetes Screening Criteria Miss Half of Patients

Published: Fri, 20 Apr 2018 17:11:32 EDT
Current diabetes screening criteria miss half of patients with diabetes and prediabetes; using an expanded version could identify many more high-risk individuals.
Medscape Medical News

Wearable Wrist Device Relieves Symptoms in Essential Tremor

Published: Fri, 20 Apr 2018 16:48:33 EDT
Noninvasive peripheral nerve stimulation is safe and effective in reducing tremors in patients with essential tremor, early research shows.
Medscape Medical News

Successful Treatment in UK Very Resistant Gonorrhea Case

Published: Fri, 20 Apr 2018 16:32:00 EDT
Ertapenem antibiotic treatment has been successful for a man from the UK who acquired a strain of 'very resistant gonorrhea' while on vacation in Southeast Asia.
Medscape Medical News
Displaying results 1-4 (of 20)
 1 - 2 - 3 - 4 - 5 


A compound from immune cells could treat psoriasis, other autoimmune diseases

Published: Fri, 20 Apr 2018 15:49:52 +0000
Itaconate, a compound produced by inflammatory cells, relieved psoriasis-like symptoms in mice. It could have uses beyond psoriasis as it targets the IL-17 pathway, which is implicated in many autoimmune diseases.

Gene editing shows promise in combating HIV reservoirs

Published: Fri, 20 Apr 2018 15:30:00 +0000
Gene therapy has experienced a renaissance of late, and it’s a technology that many researchers in HIV are embracing. That's because the ability to manipulate genes—particularly CCR5, which is known to play a role in HIV resistance—could help eliminate dormant reservoirs of virus that can resurge at any time.

UCB offers $370M for Proximagen’s epilepsy spray, with NDA to follow

Published: Fri, 20 Apr 2018 13:59:47 +0000
UCB plans to bolster its epilepsy portfolio by acquiring a nasal spray developed by Proximagen, agreeing to pay $150 million up front, with biobucks of $220 million also in the cards.

Biogen pays Ionis $1B to form discovery-stage pact

Published: Fri, 20 Apr 2018 12:28:00 +0000
Biogen is paying $1 billion to enter into a discovery-stage R&D pact with Ionis Pharmaceuticals. The deal gives Biogen a chance to pick up a series of neurological antisense drugs identified by Ionis.
Displaying results 1-4 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy